KN
Kumaresh Nandi
About Kumaresh Nandi
Data last updated:
Kumaresh Nandi is a Director at Futurewell Pharmaceuticals Private Limited (since 2023). The company operates in Chemicals. Futurewell Pharmaceuticals Private Limited reported revenue of ₹37.9 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Futurewell Pharmaceuticals Private Limited U24100WB2023PTC259827 | Director | 13 Jan 2023 | 2023 | ₹37.9 Lakh (FY 2024) | Active |
Board colleagues of Kumaresh Nandi
| Name | DIN | Company | Designation |
|---|---|---|---|
| Dipankar Shome | 11573203 | Futurewell Pharmaceuticals Private Limited | Director |
| Sudha Jha Nandi | 09859560 | Futurewell Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kumaresh Nandi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kumaresh Nandi
Kumaresh Nandi currently holds 1 directorship: Futurewell Pharmaceuticals Private Limited (Director, since 13 Jan 2023, revenue ₹37.9 Lakh (FY 2024)).
Kumaresh Nandi was first appointed on 13 Jan 2023 as Director at Futurewell Pharmaceuticals Private Limited.
The current boards of Kumaresh Nandi's companies include Dipankar Shome (Futurewell Pharmaceuticals Private Limited), Sudha Jha Nandi (Futurewell Pharmaceuticals Private Limited).